159 related articles for article (PubMed ID: 17020652)
1. [Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents].
Głowińska-Olszewska B; Urban M; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):179-83. PubMed ID: 17020652
[TBL] [Abstract][Full Text] [Related]
2. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
Głowińska-Olszewska B; Urban M
Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313
[TBL] [Abstract][Full Text] [Related]
3. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
Głowińska B; Urban M; Peczyńska J; Florys B
Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
[TBL] [Abstract][Full Text] [Related]
4. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
Florys B; Głowińska B; Urban M; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of matrix metaloproteinase 2 (MMP-2), matrix metaloproteinase 9 (MMP-9) and tissue inhibitor of metaloproteinase 2 (TIMP-2) in children and adolescents with growth hormone deficiency].
Szczepańska-Kostro J; Kowalewski M; Urban M; Gardziejczyk M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):257-60. PubMed ID: 17239302
[TBL] [Abstract][Full Text] [Related]
7. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 and -9 levels in obese patients.
Derosa G; Ferrari I; D'Angelo A; Tinelli C; Salvadeo SA; Ciccarelli L; Piccinni MN; Gravina A; Ramondetti F; Maffioli P; Cicero AF
Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus.
Derosa G; Avanzini MA; Geroldi D; Fogari R; Lorini R; De Silvestri A; Tinelli C; Rondini G; d'Annunzio G
Diabetes Res Clin Pract; 2005 Nov; 70(2):119-25. PubMed ID: 16188574
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
Chau KY; Sivaprasad S; Patel N; Donaldson TA; Luthert PJ; Chong NV
Eye (Lond); 2008 Jun; 22(6):855-9. PubMed ID: 18597988
[TBL] [Abstract][Full Text] [Related]
11. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
12. Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Solini A; Santini E; Passaro A; Madec S; Ferrannini E
J Hum Hypertens; 2009 Dec; 23(12):801-7. PubMed ID: 19339995
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A
Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245
[TBL] [Abstract][Full Text] [Related]
15. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
Derosa G; D'Angelo A; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Tinelli C; Cicero AF
Endothelium; 2006; 13(3):227-31. PubMed ID: 16840178
[TBL] [Abstract][Full Text] [Related]
17. [Selected adhesion molecules: sICAM-1 and sVCAM-1 as markers of endothelial dysfunction in diabetic children and adolescence].
Głowińska B; Urban M; Peczyńska J; Szczepańska-Kostro J
Pol Merkur Lekarski; 2003 Mar; 14(81):205-9. PubMed ID: 12914095
[TBL] [Abstract][Full Text] [Related]
18. Plasma matrix metalloproteinase-9 levels and blood pressure in short children born small for gestational age and effects of growth hormone treatment.
Willemsen RH; van Dijk M; de Kort SW; van Toorenenbergen AW; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Aug; 69(2):264-8. PubMed ID: 18284641
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
Chau KY; Sivaprasad S; Patel N; Donaldson TA; Luthert PJ; Chong NV
Eye (Lond); 2007 Dec; 21(12):1511-5. PubMed ID: 17304258
[TBL] [Abstract][Full Text] [Related]
20. The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.
Zervoudaki A; Economou E; Pitsavos C; Vasiliadou K; Aggeli C; Tsioufis K; Toutouza M; Stefanadis C; Toutouzas P
Am J Hypertens; 2004 Mar; 17(3):273-6. PubMed ID: 15001203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
